The most important aspect of this study compared with former experiments that used other pharmacological NF-κB inhibitors is that the inhibitor used in this study effectively prevented bone invasion upon initiation of 5 mg/kg IMD-0560 injection at a relatively advanced stage of tumor growth. The gene discussed is NFKB1; the disease is neoplasm.